课题基金 / 基金详情

Mitotic Checkpoint Proteins in Tumorigenesis

Mitotic Checkpoint Proteins in Tumorigenesis
有丝分裂检查点蛋白在肿瘤发生中的作用
批准号:
6912547
负责人:
FRANK D. MCKEON
金额:
$37.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-07-18 至 2007-06-30

项目摘要

项目成果

FRANK D. MCKEON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (provided by applicant) The mitotic checkpoint describes molecular controls that monitor chromosome segregation, a process that ensures the faithful transfer of a cell's genome to its progeny. Should any of these steps fail, the mitotic checkpoint triggers a cell cycle arrest to provide additional time to complete the process before cell division. Arguably more important to tumorigenesis, but largely unexplored, is a second function of the mitotic checkpoint- inducing cell death when division occurs without proper chromosome segregation. Recently, the mitotic checkpoint has come under increased scrutiny because many cancer cells show chromosomal aneuploidy, at least some of which can be explained by a genetically dominant chromosome instability (GIN) phenotype. This chromosome instability may in fact be acting early in tumorigenesis to promote the rapid loss and gain of tumor suppressors and proto-oncogenes, respectively. Taken together, these findings suggest a critical link between the mitotic checkpoint and cancer pathways. This is a proposal to decipher the mechanisms underlying the second function of the mitotic checkpoint, that of killing cells which undergo abnormal chromosome segregation. Preliminary data support the hypothesis that cells showing abnormal chromosome segregation are killed in a manner dependent on signaling from two mitotic checkpoint proteins, BUB1 and MAD3L, to the tumor suppressor p53. We want to determine how BUB 1 and MAD3L, which appear to monitor successive phases of chromosome segregation, signal failures and whether both of these signals act through p53 stabilization. Finally, we will develop murine models that test the consequences of defects in the mitotic checkpoint on tumorigenesis, as well as develop models to further decipher the biochemical pathways between the checkpoint signaling molecules and p53. We anticipate that these studies will address an important hypothesis for the generation of cancers and contribute to our understanding and prevention of these diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pro-Inflammatory Stem Cell Variants in Cystic Fibrosis
  • 批准号:
    10367503
  • 项目类别:
  • 资助金额:
    $69.18万
  • 财政年份:
    2022
  • 负责人:
    FRANK D. MCKEON
  • 依托单位:
Patient-Matched Stem Cells of the Barrett's-Dysplasia-Adenocarcinoma Sequence
  • 批准号:
    10607403
  • 项目类别:
  • 资助金额:
    $13.5万
  • 财政年份:
    2022
  • 负责人:
    FRANK D. MCKEON
  • 依托单位:
Pro-Inflammatory Stem Cell Variants in Cystic Fibrosis
  • 批准号:
    10557166
  • 项目类别:
  • 资助金额:
    $67.81万
  • 财政年份:
    2022
  • 负责人:
    FRANK D. MCKEON
  • 依托单位:
Clonal Reconstruction and Targeting of the Correa Sequence
  • 批准号:
    10470091
  • 项目类别:
  • 资助金额:
    $55.08万
  • 财政年份:
    2019
  • 负责人:
    FRANK D. MCKEON
  • 依托单位:
海外基金